CFM Wealth Partners’s Pulmonx LUNG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$343K Hold
264,039
0.04% 118
2026
Q1
$341K Hold
264,039
0.05% 120
2025
Q4
$584K Hold
264,039
0.08% 94
2025
Q3
$428K Hold
264,039
0.06% 108
2025
Q2
$684K Hold
264,039
0.11% 84
2025
Q1
$1.78M Hold
264,039
0.31% 61
2024
Q4
$1.79M Hold
264,039
0.3% 59
2024
Q3
$2.19M Hold
264,039
0.38% 55
2024
Q2
$1.67M Hold
264,039
0.31% 61
2024
Q1
$2.45M Hold
264,039
0.49% 52
2023
Q4
$3.37M Hold
264,039
0.76% 36
2023
Q3
$2.73M Hold
264,039
0.71% 40
2023
Q2
$3.46M Hold
264,039
0.84% 32
2023
Q1
$2.95M Hold
264,039
0.8% 38
2022
Q4
$2.23M Buy
+264,039
New +$2.51M 0.67% 45

Other funds holding LUNG

CFM Wealth Partners's LUNG Position: Q2 2026 in Review

CFM Wealth Partners held its Pulmonx (LUNG) position steady in Q2 2026 at 264,039 shares worth $343K. The position accounts for 0.04% of the portfolio, ranked #118.

CFM Wealth Partners first reported a position in LUNG in Q4 2022 and has held it in 15 quarters since. The position peaked at $3.46M in Q2 2023. 108 funds tracked by Wall St. Rank hold LUNG as of Q2 2026.

  • CFM Wealth Partners held 264,039 shares of Pulmonx worth $343K as of Q2 2026.
  • CFM Wealth Partners left its Pulmonx share count unchanged in Q2 2026.
  • Pulmonx made up 0.04% of CFM Wealth Partners's portfolio in Q2 2026, its #118 holding.
  • CFM Wealth Partners first reported a position in Pulmonx in Q4 2022 and has held it in 15 quarters since.
  • CFM Wealth Partners's Pulmonx position peaked at $3.46M in Q2 2023.
  • 108 funds tracked by Wall St. Rank held Pulmonx as of Q2 2026.

Based on CFM Wealth Partners's 13F filing for Q2 2026, filed 7 Aug 2026.